Lymphocyte apoptosis is resistant to erythropoietin in porcine endotoxemia

APMIS

Volumn 119, Issue 2, 2011, Pages 143-154

  Sølling, Christoffer ^a,b   Nygaard, Uffe ^a,b   Christensen, Anton T ^a,b   Wogensen, Lise ^a,b   Krog, Jan ^a,b   Tønnesen, Else K ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Apoptosis; Endotoxemia; Erythropoietin; Mononuclear cells

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ENDOTOXEMIA; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LYMPHOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SPLEEN BIOPSY; SWINE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; APOPTOSIS; CASPASE 3; ENDOTOXEMIA; ERYTHROPOIETIN, RECOMBINANT; FEMALE; LEUKOCYTE COUNT; LYMPHOCYTES; SWINE;

EID: 78650802377     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02704.x     Document Type: Article

References (41)

1. Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008;26:711-15.
2. Kox WJ, Volk T, Kox SN, Volk HD. Immunomodulatory therapies in sepsis. Intensive Care Med 2000;26(Suppl 1):124-8.
3. Hartemink KJ, Paul MA, Spijkstra JJ, Girbes AR, Polderman KH. Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med 2003;29:2068-71.
4. Volk HD, Reinke P, Docke WD. Clinical aspects: from systemic inflammation to 'immunoparalysis'. Chem Immunol 2000;74:162-77.
5. Rajan G, Sleigh JW. Lymphocyte counts and the development of nosocomial sepsis. Intensive Care Med 1997;23:1187.
6. Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 2005;174:3765-72.
7. Toti P, De FC, Occhini R, Schuerfeld K, Stumpo M, Epistolato MC, et al. Spleen depletion in neonatal sepsis and chorioamnionitis. Am J Clin Pathol 2004;122:765-71.
8. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, Chang KC, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001;166:6952-63.
9. Weber SU, Schewe JC, Lehmann LE, Muller S, Book M, Klaschik S, et al. Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. Crit Care 2008;12:R128.
10. Freire-de-Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, De Mello FG, et al. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 2000;403:199-203.
11. Hotchkiss RS, Chang KC, Grayson MH, Tinsley KW, Dunne BS, Davis CG, et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci USA 2003;100:6724-9.
12. Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 2000;1:496-501.
13. Wesche-Soldato DE, Chung CS, Lomas-Neira J, Doughty LA, Gregory SH, Ayala A. In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood 2005;106:2295-301.
14. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004;15:2115-24.
15. Ates E, Yalcin AU, Yilmaz S, Koken T, Tokyol C. Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg 2005;75:1100-5.
16. Cuzzocrea S, Di PR, Mazzon E, Patel NS, Genovese T, Muia C, et al. Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med 2006;34:1168-77.
17. Patel NS, Sharples EJ, Cuzzocrea S, Chatterjee PK, Britti D, Yaqoob MM, et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 2004;66:983-9.
18. Aoshiba K, Onizawa S, Tsuji T, Nagai A. Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit Care Med 2009;37:889-98.
19. Kokhaei P, Abdalla AO, Hansson L, Mikaelsson E, Kubbies M, Haselbeck A, et al. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies. Clin Cancer Res 2007;13:3536-44.
20. Strunk T, Hartel C, Temming P, Matzke N, Zimmer J, Schultz C. Erythropoietin inhibits cytokine production of neonatal and adult leukocytes. Acta Paediatr 2008;97:16-20.
21. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 1994;170:145-57.
22. Lecoeur H, Gougeon ML. Comparative analysis of flow cytometric methods for apoptosis quantitation in murine thymocytes and human peripheral lymphocytes from controls and HIV-infected persons. Evidence for interference by granulocytes and erythrocytes. J Immunol Methods 1996;198:87-99.
23. Ebdrup L, Krog J, Granfeldt A, Tonnesen E, Hokland M. Dynamic expression of the signal regulatory protein alpha and CD18 on porcine PBMC during acute endotoxaemia. Scand J Immunol 2008;68:430-7.
24. Zhang YH, Takahashi K, Jiang GZ, Kawai M, Fukada M, Yokochi T. In vivo induction of apoptosis (programmed cell death) in mouse thymus by administration of lipopolysaccharide. Infect Immun 1993;61:5044-8.
25. Norimatsu M, Ono T, Aoki A, Ohishi K, Takahashi T, Watanabe G, et al. Lipopolysaccharide-induced apoptosis in swine lymphocytes in vivo. Infect Immun 1995;63:1122-6.
26. Haendeler J, Messmer UK, Brune B, Neugebauer E, Dimmeler S. Endotoxic shock leads to apoptosis in vivo and reduces Bcl-2. Shock 1996;6:405-9.
27. Nielsen JS, Larsson A, Brix-Christensen V, Nyengaard JR, Ledet T, Tonnesen E. Endotoxemia-induced lymphocyte apoptosis is augmented by a hyperinsulinemic-euglycemic clamp. Anesthesiology 2005;102:768-73.
28. Sarkar S, Kalia V, Montelaro RC. Caspase-mediated apoptosis and cell death of rhesus macaque CD4+ T-cells due to cryopreservation of peripheral blood mononuclear cells can be rescued by cytokine treatment after thawing. Cryobiology 2003;47:44-58.
29. Wen D, Boissel JP, Tracy TE, Gruninger RH, Mulcahy LS, Czelusniak J, et al. Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood 1993;82:1507-16.
30. Pearson PL, Smith TP, Sonstegard TS, Klemcke HG, Christenson RK, Vallet JL. Porcine erythropoietin receptor: molecular cloning and expression in embryonic and fetal liver. Domest Anim Endocrinol 2000;19:25-38.
31. Kovacevic M, Bozic T, Ivanovic Z. Erythroid progenitor cells from pig bone marrow and peripheral blood. Vet J 1999;158:196-203.
32. Forman CJ, Johnson DW, Nicol DL. Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs. BJU Int 2007;99:162-5.
33. Simon F, Scheuerle A, Calzia E, Bassi G, Oter S, Duy CN, et al. Erythropoietin during porcine aortic balloon occlusion-induced ischemia/reperfusion injury. Crit Care Med 2008;36:2143-50.
34. Shimoda M, Sawada T, Iwasaki Y, Mori S, Kijima H, Okada T, et al. Erythropoietin strongly protects the liver from ischemia-reperfusion injury in a pig model. Hepatogastroenterology 2009;56:470-5.
35. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009;40:e647-e656.
36. Tonelli M, Hemmelgarn B, Reiman T, Manns B, Reaume MN, Lloyd A, et al. Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis. CMAJ 2009;180:E62-E71.
37. Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 2009;373:1532-42.
38. Sinclair AM, Coxon A, McCaffery I, Kaufman S, Paweletz K, Liu L, et al. Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells. Blood 2010;115:4264-72.
39. Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, et al. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 2006;107:1892-5.
40. Laugsch M, Metzen E, Svensson T, Depping R, Jelkmann W. Lack of functional erythropoietin receptors of cancer cell lines. Int J Cancer 2008;122:1005-11.
41. Haverson K, Saalmuller A, Alvarez B, Alonso F, Bailey M, Bianchi AT, et al. Overview of the third international workshop on swine leukocyte differentiation antigens. Vet Immunol Immunopathol 2001;80:5-23.